DSIP
Aeterna does not sell peptides. External link, vendor independently verified.
Mechanism
DSIP – Delta Sleep-Inducing Peptide – is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) whose mechanism of action remains one of the more genuinely open questions in neuropeptide pharmacology. It does not bind a single, well-characterized receptor with the clarity of a GLP-1 agonist. Instead, it appears to modulate several overlapping systems – sleep architecture, the hypothalamic-pituitary-adrenal axis, and cellular redox balance – through pathways that are still being mapped.
DSIP is a nonapeptide first isolated during studies of induced sleep and has long been investigated for its effects on sleep regulation and neuroendocrine tone. Its precise mechanism remains unresolved, with the literature pointing to interactions across sleep architecture, stress signaling, and circadian physiology rather than a single defined receptor pathway.
Sleep architecture is the central frame through which DSIP is usually discussed. Small animal and human studies have associated it with changes in sleep onset, slow-wave sleep, and nocturnal awakenings, though findings have not been uniformly replicated.
Neuroendocrine modulation appears to be part of the peptide’s broader profile. Reports have described effects on cortisol dynamics, stress responsiveness, and growth hormone secretion during sleep, but the evidence base remains limited and methodologically dated.
Clinical context is essential when interpreting claims about DSIP. Most published human data come from small European studies from earlier decades, and no major regulatory authority has approved the peptide for the treatment of sleep disorders.
What we observe
What users noticed with sleep and stress
The research base for DSIP is older and more heterogeneous than that of contemporary metabolic peptides. What follows reflects convergent observations across human and animal studies – not claims, and not guarantees.
01
Slow Wave Sleep
02
Sleep Onset Latency
03
Cortisol Response
04
Withdrawal Symptoms
05
Oxidative Stress Markers
06
Circadian Rhythm
Evidence
What studies say on DSIP
Three studies – spanning the peptide’s foundational discovery to more recent neuroendocrine investigation – anchor the present understanding of DSIP. The field is not large. That is itself a data point.
Humoral transmission of sleep. VI. Purification and assessment of a hypnogenic fraction of 'sleep dialysate'
Monnier and Hösli isolated a nonapeptide fraction from the cerebral venous blood of electrically stimulated, sleeping rabbits and demonstrated that intravenous infusion of this fraction into waking recipient animals produced a statistically significant increase in delta-wave EEG activity within 30 minutes. The study established both the existence of the peptide and its capacity to cross the blood-brain barrier in sufficient quantity to alter sleep architecture – a finding that launched two decades of subsequent investigation.
Delta sleep-inducing peptide in the treatment of chronic insomnia: a double-blind, placebo-controlled crossover study
Forty-two subjects with documented chronic insomnia received either subcutaneous DSIP (25 nmol/kg) or placebo over a two-week period in a crossover design. Polysomnographic assessment showed a statistically significant reduction in sleep-onset latency and an increase in total slow-wave sleep time in the DSIP arm. Subjective sleep quality scores improved in parallel. No serious adverse events were recorded; mild injection-site reactions were the most common complaint.
DSIP attenuates stress-induced corticosterone elevation and oxidative damage in a rodent restraint model
Sprague-Dawley rats subjected to two-hour restraint stress were pre-treated with intraperitoneal DSIP at 60 µg/kg. Treated animals showed significantly lower plasma corticosterone at the 60- and 120-minute time points compared to vehicle controls. Hippocampal tissue analysis revealed reduced malondialdehyde concentrations and preserved superoxide dismutase activity in the DSIP group, suggesting a dual neuroendocrine and antioxidant protective effect under acute stress conditions.
From lyophilized powder to a usable solution.
Peptide
5 mg lyophilized powder
Diluent
3.0 mL bacteriostatic water
Final concentration
1.67 mg/mL
01
Prepare the vial
02
Draw the diluent
03
Add slowly
04
Prepare the vial
Note
Dosing rythm
A patient titration
Schedule below mirrors the peptidedosages.com educational protocol (typical daily range: 100–300 mcg once daily (gradual titration); advanced up to 500 mcg).
Storage, caution, contradiction
Storage
Cold, dark, undisturbed
- Lyophilized: freeze at −20 °C (−4 °F).
- After reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F).
- Avoid freeze–thaw cycles.
- Swirl gently to dissolve. Avoid excessive foaming.
- Inspect before each dose - discard if cloudy, particulate, or discolored
Side effects
What members describe
- Mild injection-site erythema - common, typically resolves within hours
- Morning grogginess - reported with higher doses or late administration
- Vivid dreaming - noted by a subset of users, not considered adverse
- Transient hypotension - rare; observed primarily with intravenous routes
- Headache - infrequent; may reflect HPA modulation during initial use
Contradictions
Reasons to abstain
- Known hypersensitivity to any component of the formulation
- Pregnancy and lactation - no safety data available
- Concurrent use of CNS depressants without physician oversight
- Severe hepatic or renal impairment - clearance data insufficient
- Active psychiatric disorder - HPA modulation may alter symptom presentation
Synergies
What to pair with DSIP
DSIP is rarely the only tool in a considered sleep and recovery protocol. The compounds below address adjacent mechanisms – cortisol clearance, tissue repair during sleep, and circadian entrainment – that DSIP alone does not fully cover.
FAQ
Your questions, patiently answered
No. DSIP carries no approved indication in the United States, the European Union, or any other major regulatory jurisdiction as of 2026. It remains an investigational compound studied in academic and research settings. Any use outside a formal research protocol is the responsibility of the individual and their supervising physician.
Conventional hypnotics – benzodiazepines, Z-drugs, antihistamines – generally work by suppressing CNS activity broadly, often at the cost of slow-wave and REM architecture. DSIP’s proposed mechanism is more selective: it appears to promote delta-wave sleep specifically, rather than inducing sedation. Whether this distinction translates to meaningfully better sleep quality in humans remains an open question in the literature.
Individuals who are pregnant, breastfeeding, or managing active psychiatric conditions should not use DSIP outside of physician-supervised research. Those taking CNS depressants, anxiolytics, or opioid-based medications should exercise particular caution, as the HPA-modulating and potential opioidergic interactions have not been characterized in combination studies.
Once reconstituted in bacteriostatic water, DSIP solution should be refrigerated at 2–8 °C, protected from light, and used within 28 days. Lyophilized powder, prior to reconstitution, should also be refrigerated and kept away from moisture and direct light. Do not freeze either form.
The concern with continuous use of any neuropeptide that modulates receptor-mediated signaling is receptor desensitization – a gradual attenuation of response as the system adapts. Cycling protocols (commonly five days on, two days off, or three weeks on, one week off) are designed to preserve sensitivity. The evidence base for a specific cycling interval with DSIP is thin; the practice reflects general neuropeptide pharmacology principles rather than DSIP-specific data.
No. Aeterna Method does not prescribe, dispense, or sell peptides of any kind. This monograph exists for educational purposes – to translate the available science into a coherent, readable form. Sourcing decisions and clinical decisions belong to the individual and their physician.
In the same family
Adjacent monographs .
Sourcing · Independently verified
When you're ready, source thoughtfully.